Jianmin Fang1 article listing Jianmin Fang in Nature Communications, indexed by Paperzzz from Crossref and OSF.Disitamab vedotin for HER2-positive breast cancer with liver metastases: phase 3 results from the RC48-C006 phase 2/3 trial Nature Communications